Disease landscape

Heart Failure clinical trials

Get alerts when Heart Failure trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

131 trials changed in the last 30 days: 3 stopped, 60 with notable changes, 68 with minor changes only.

  1. Stopped

    ICAME · Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker · Acute Heart Failure

    Trial terminated

    Also in this update: Study completion date changed from estimate of Jan 2027 to Apr 14, 2026; Final enrollment: 154 participants (planned 710)

    University Hospital, MontpellierNot applicable NCT04554277 Registry history of NCT04554277 on ClinicalTrials.gov (opens the registry)

  2. Notable

    ELASTOCARDIO2 · Noninvasive Elastography Evaluation of Myocardial Stiffness · Isolated Diastolic Heart Failure: New Diagnostic Tool?

    Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026

    Also in this update: Primary endpoint(s) modified; Enrollment increased: 90 → 140 participants

    French Cardiology SocietyNot applicable NCT03895541 Registry history of NCT03895541 on ClinicalTrials.gov (opens the registry)

Show 68 trials with minor changes only
  1. Minor

    ADMINISTER II · Impact of Nudging Cardiologists to Prescribe Class I Recommendations Foundational- and Additional Medical Therapy in Heart Failure Patients

    Trial status changed: Enrolling by Invitation → Active, Not Recruiting

    Also in this update: Study completion moved earlier from Aug 31, 2028 to Jul 9, 2028; Primary completion moved earlier from Mar 30, 2028 to Jan 9, 2028

    Medisch Spectrum TwenteNot applicable NCT06844006 Registry history of NCT06844006 on ClinicalTrials.gov (opens the registry)

  2. Minor

    PreVail-PH2 · Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure · Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

    Primary completion pushed from Dec 2026 to Jun 2027

    Also in this update: Study completion pushed from Jul 1, 2028 to Jun 1, 2030

    Gradient Denervation TechnologiesNot applicable NCT06052072 Registry history of NCT06052072 on ClinicalTrials.gov (opens the registry)

  3. Minor

    Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

    Trial completed

    Also in this update: Primary completion date changed from estimate of Nov 30, 2025 to Jun 30, 2025; Final enrollment: 160 participants (planned 120)

    Chinese University of Hong KongNot specified NCT05797649 Registry history of NCT05797649 on ClinicalTrials.gov (opens the registry)

  4. Minor

    The PULSE-LHD · Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy · Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

    Trial sites expanded: 13 → 16 locations

    And 1 more change in the last 30 days

    Pulnovo Medical, Inc.Not applicable NCT07214376 Registry history of NCT07214376 on ClinicalTrials.gov (opens the registry)

  5. Minor
    21 trials marked Unknown by the registry's verification sweep
    1. Minor

      Impact of Cardiac Rehabilitation Exercise Therapy on the Quality of Life · Chronic Heart Failure

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

      Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityNot applicable NCT06633107 Registry history of NCT06633107 on ClinicalTrials.gov (opens the registry)

      Changed

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-10-16 NCT07877831 Vericiguat Use and Incident Atrial Fibrillation in Chronic Heart Failure Beijing Tsinghua Chang Gung Hospital new
2026-10-13 NCT07870369 Cardiovascular Risk in Patients With Primary Hyperparathyroidism Medical University of Sofia new
2026-10-07 NCT07864363 Rhythmic Auditory Stimulation in Heart Failure Patients Necmettin Erbakan University new
2026-10-02 NCT07855692 The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial) Nagoya University new Phase 2
2026-09-30 NCT07849361 Feasibility Study on the Implementation of a Program to Facilitate the Return Home of… Sant'Innovation new
2026-09-30 NCT07848529 Clinical Evidence With Biomarker Confirmation for PPMI in PCI Clinical Trials Study Baim Institute for Clinical Research new
2026-09-29 NCT07847983 Heart Failure in Women: Epidemiological and Prognostic Insights Carolina Ortiz Cortes new
2026-09-25 NCT07842874 A Comparison of Left Bundle Branch Optimized Cardiac Resynchronization Therapy vs Left… PD Dr. Guram Imnadze new
2026-09-21 NCT07830758 Resmetirom in Patients With MASH and HFpEF Madrigal Pharmaceuticals, Inc. new Phase 1
2026-09-17 NCT07823998 Coffee Use, Physical Activity and Symptomatic Ventricular Arrhythmias in Patients With… Jean-Benoît Le Polain de Waroux new

Active trials by phase

Early Phase 1
10
Phase 1
34
Phase 1/2
24
Phase 2
71
Phase 2/3
13
Phase 3
70
Phase 4
81
Not charted: 1,251 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Top sponsors by active trials in this area

Get alerts when Heart Failure trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free

Narrower conditions

Active trials